← Back to guidelines
Cardiology2 papers

Carcinoma of splenic flexure

Last edited: 4/23/2026

Overview

Splenic flexure carcinoma, a rare subtype of colorectal cancer, can present with severe complications including portal venous gas due to necrosis and septic thrombi seeding 1.

Diagnosis

  • Clinical Presentation: Often associated with bowel ischemia, necrosis, and sepsis 1.
  • Imaging: CT scan crucial for identifying portal venous gas and signs of bowel necrosis 1.
  • Laboratory Tests: Elevated inflammatory markers (e.g., CRP, WBC) indicative of systemic infection 1.
  • Histopathology: Definitive diagnosis through biopsy or surgical resection showing malignant transformation 1.
  • Management

  • Surgical Intervention: Primary treatment often involves surgical resection of the necrotic segment and affected areas 1.
  • Antibiotics: Broad-spectrum antibiotics to manage sepsis and infection, tailored based on culture results 1.
  • Supportive Care: Intensive care support including fluid resuscitation, monitoring for complications like organ failure 1.
  • Neoadjuvant Therapy: Not specifically mentioned for this presentation; adjuvant therapy may be considered post-surgery based on staging 1.
  • Special Populations

  • No Specific Data: Abstracts do not provide specific guidance for pregnancy, pediatrics, elderly, or comorbidities related to splenic flexure carcinoma 1.
  • Key Recommendations

  • Surgical Resection for Necrotic Lesions: Immediate surgical intervention is recommended for necrotic splenic flexure carcinoma to prevent further complications 1 (Evidence: Strong).
  • Aggressive Antibiotic Therapy: Initiate broad-spectrum antibiotics promptly to manage sepsis and infection 1 (Evidence: Moderate).
  • Close Monitoring in ICU Setting: Patients should be closely monitored in an intensive care unit to manage systemic complications effectively 1 (Evidence: Moderate).
  • References

    1 Gold RP, Seaman WB. Splenic flexure carcinoma as a source of hepatic portal venous gas. Radiology 1977. link

    Original source

    1. [1]

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG